Diversify Advisory Services LLC Has $2.13 Million Stake in Zoetis Inc. (NYSE:ZTS)

Diversify Advisory Services LLC lessened its holdings in Zoetis Inc. (NYSE:ZTS) by 16.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,047 shares of the company’s stock after selling 2,593 shares during the quarter. Diversify Advisory Services LLC’s holdings in Zoetis were worth $2,131,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Pensionfund Sabic boosted its stake in Zoetis by 55.6% in the 4th quarter. Pensionfund Sabic now owns 11,200 shares of the company’s stock valued at $1,825,000 after buying an additional 4,000 shares in the last quarter. PFW Advisors LLC acquired a new stake in shares of Zoetis during the fourth quarter worth approximately $1,764,000. JPMorgan Chase & Co. increased its holdings in shares of Zoetis by 10.6% during the third quarter. JPMorgan Chase & Co. now owns 2,916,539 shares of the company’s stock worth $569,834,000 after buying an additional 279,092 shares in the last quarter. Simplify Asset Management Inc. bought a new position in shares of Zoetis in the third quarter valued at approximately $11,684,000. Finally, B&L Asset Management LLC acquired a new position in Zoetis in the third quarter worth $563,000. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on ZTS. Leerink Partnrs upgraded shares of Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. Stifel Nicolaus reduced their price objective on Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Leerink Partners initiated coverage on Zoetis in a research report on Monday, December 2nd. They set an “outperform” rating and a $215.00 target price for the company. UBS Group began coverage on Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target on the stock. Finally, JPMorgan Chase & Co. lifted their price target on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. One research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Zoetis currently has an average rating of “Buy” and an average target price of $211.89.

Zoetis Trading Down 2.0 %

ZTS opened at $166.01 on Monday. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $200.53. The firm has a market cap of $74.90 billion, a PE ratio of 31.20, a price-to-earnings-growth ratio of 2.51 and a beta of 0.89. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. The firm’s fifty day moving average is $170.93 and its two-hundred day moving average is $179.98.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The business had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.29 billion. During the same quarter in the previous year, the business posted $1.36 EPS. Zoetis’s revenue for the quarter was up 11.6% on a year-over-year basis. Equities research analysts anticipate that Zoetis Inc. will post 5.91 EPS for the current year.

Zoetis Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. This represents a $2.00 dividend on an annualized basis and a yield of 1.20%. Zoetis’s dividend payout ratio is presently 32.52%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.